Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-25

Clinical Trial Update: Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluating mesenchymal stem cell therapy with conditioned medium for knee osteoarthritis, sponsored by PT. Prodia Ste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Conditioned Medium Therapy (mesenchymal stem cell conditioned medium)
  • Mesenchymal Stem Cell Therapy (MSCs) (mesenchymal stem cells)

Snippet

Sponsor: PT. Prodia Stem Cell Indonesia | Conditions: Osteoarthritis, Knee | Phase 1, Phase 2 | Status: COMPLETED